Related Experiment Video
Updated: Jul 13, 2025
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
MET exon 14 skipping is overexpressed in an allele-specific manner in lung adenocarcinoma primary samples
Megan Durham1, Swetha Vadde1, Angela N Brooks2
1Department of Molecular, Cell and Developmental Biology, University of California, Santa Cruz, Santa Cruz, California, United States.
Abstract:
MET exon 14 skipping ( METΔ14 ) is a well-characterized oncogene in the Ras-MAPK pathway driving lung adenocarcinoma (LUAD). Previous studies on METΔ14 revealed this aberrantly spliced oncogene is expressed in LUAD primary samples and is associated with heterozygous somatic mutations and deletions near exon 14 splice sites. Upon further examination of DNA and RNA sequencing data from primary samples, we highlight that METΔ14 is overexpressed in an allele-specific manner. These data suggest that dose-dependence of METΔ14 may be critical to oncogenesis.
Insights
MET exon 14 skipping (METΔ14) drives lung adenocarcinoma (LUAD). This oncogene is overexpressed in an allele-specific manner, suggesting its dosage is critical for cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MET exon 14 skipping (METΔ14) is a known oncogene implicated in the Ras-MAPK pathway.
- METΔ14 is aberrantly spliced and found in lung adenocarcinoma (LUAD) primary samples.
- Previous research linked METΔ14 to somatic mutations and deletions near splice sites.
Purpose of the Study:
- To investigate the expression pattern of METΔ14 in LUAD.
- To determine if METΔ14 expression is allele-specific.
- To explore the potential role of METΔ14 dosage in oncogenesis.
Main Methods:
- Analysis of DNA and RNA sequencing data from LUAD primary samples.
- Examination of allele-specific expression patterns.
Main Results:
- METΔ14 is overexpressed in LUAD primary samples.
- This overexpression occurs in an allele-specific manner.
- Data indicate a potential dose-dependent effect of METΔ14 in cancer development.
Conclusions:
- METΔ14 overexpression in an allele-specific manner is a key feature in LUAD.
- The dosage of METΔ14 may be a critical factor in the oncogenesis of lung adenocarcinoma.
